ALXO Earnings

Quarterly EPS
$-0.58
Q3 2024
$-0.54
Q4 2024
$-0.58
Q1 2025
$-0.49
Q2 2025
$-0.41
Q3 2025
$-0.42
Q4 2025
$-0.17
Q1 2026
$-0.13
Q2 2026
Latest RevenueN/A
Latest Net Income-17971000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.130-17971000—+73.5%
Q1 2026-$0.170-17927000—+70.7%
Q4 2025-$0.420-22848000—+22.2%
Q3 2025-$0.410-22144000—+29.3%
Q2 2025-$0.490-25949000—+35.5%
Q1 2025-$0.580-30754000—+18.3%
Q4 2024-$0.540-29163000—+41.9%
Q3 2024-$0.580-30707000—+53.2%
Q2 2024-$0.760-39399000——
Q1 2024-$0.710-35581000——
Q4 2023-$0.930-45472000——
Q3 2023-$1.240-50990000——
ALX Oncology (ALXO) — Earnings